Top Links

Articles Related to BCS

Orodental Considerations in Thalassemia Patients

Thalassemia is one of the most common genetic disorders worldwide and presents a major public health problem and social challenge in parts where the frequency is high. The symptoms of the disorder are modulated by various environmental, racial and genetic factors. Therefore, dental specialists are obligated to have knowledge towards the nature of the disorder and its effect on dental health. Cooperation with a hematologist is recommended in every dental treatment.
View complete article: PDF  |  Full-text

An Introduction to the Approaches of Novel Drug Delivery Systems for Acquired Immune Deficiency Syndrome (AIDS)

The currently available anti HIV agents have several drawbacks such as short half life, low bioavailability, poor CNS penetration and retention, hepatic first pass metabolism, undesirable side effects and frequent dosing regimen.
View complete article: PDF  |  Full-text

Influence of Maternal Nutritional Factors on Ovarian Folliculogenesis in Cattle

Assisted reproductive technologies, such as artificial insemination and embryo transfer, have produced significant outcomes in cattle. These technologies are useful not only for improving fertility but also for increasing the rate of genetic change in beef and dairy livestock. Today, embryo transfer in cattle is both practical and commercially viable. However, bovine embryo transplantation still remains suboptimal under on-farm conditions, one of the main reasons for which may be inefficient nutritional management.
View complete article: PDF  |  Full-text

Orally Disintegrating Tablets: A Short Review

This article summarizes the advantages of orally disintegrating tablets (ODTs) as well as critical issues during evaluation of ODTs such as bioequivalence and challenges and limitations of ODTs and finally present and the future of ODTs. ODTs have received everincreasing demand and the field has become a rapidly growing area in the pharmaceutical industry.
View complete article: PDF  |  Full-text

Croscarmellose Sodium Efficiency in the Development of a Generic Capsule Formulation of Piroxicam, Comparable Dissolution Profile to the Innovator Product, Feldene

The objective of this study was to evaluate the encapsulation performance of Croscarmellose sodium, a superdisintegrant in a low-dose, poor-solubility drug formulation and the in-vitro dissolution performance of the Piroxicam capsules. Preparation, characterization and evaluation of the effects of the different concentrations of carmellose sodium and the amount of dried starch on in-vitro dissolution of Piroxicam capsules. Piroxicam was chosen for its very low solubility in biological fluids, which result in poor systemic bioavailability after oral administration. Piroxicam can be categorized as Class II drugs according to the Biopharmaceutics Classification System.
View complete article: PDF  |  Full-text

Pharmacy Compounding Quality Control and Pharmaceutical Development Strategies for Seventeen alpha Hydroxyprogesterone Caproate in Prevention of Preterm Delivery

Seventeen alpha hydroxyprogesterone caproate (17-OHPC) is the only FDA-approved drug labeled for prevention of preterm delivery. This drug is also available as a compounded product from licensed compounding pharmacies. This article reviews the FDA approval history and pharmacy compounding quality control data of 17-OHPC, as well as briefly discusses possible future pharmaceutical development strategies for 17-OHPC.
View complete article: PDF  |  Full-text


Submit Manuscript